DXCM - DEXCOM INC


71.18
-0.480   -0.674%

Share volume: 2,782,623
Last Updated: 04-28-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 1.01%

PREVIOUS CLOSE
CHG
CHG%

$71.66
-0.48
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
34%
Profitability 18%
Dept financing 42%
Liquidity 68%
Performance 40%
Company vs Stock growth
vs
994.200 M 1.114 B
119.300 M 12%
74.850 89.070
14.220 19%
Performance
5 Days
0.57%
1 Month
4.23%
3 Months
-17.64%
6 Months
-1.47%
1 Year
-43.42%
2 Year
-39.90%
Key data
Stock price
$71.18
P/E Ratio 
52.72
DAY RANGE
$70.57 - $72.60
EPS 
$1.46
52 WEEK RANGE
$57.52 - $132.26
52 WEEK CHANGE
-$44.12
MARKET CAP 
30.377 B
YIELD 
N/A
SHARES OUTSTANDING 
400.727 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-01-2025
BETA 
0.84
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,708,575
AVERAGE 30 VOLUME 
$4,810,574
Company detail
CEO: Kevin R. Sayer
Region: US
Website: dexcom.com
Employees: 7,600
IPO year: 2005
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

DexCom, Inc. focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system.

Recent news

Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U

SAN DIEGO, April 22, 2025--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its one-of-a-kind Name, Image and Likeness program exclusively for college athletes with diabetes – for an expanded fourth season, including the first-ever nationwide open call for passionate and inspiring college athletes to join its roster.

Read more

2 Cash-Producing Stocks That Stand Out and 1 to Keep Off Your Radar

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Read more

3 Top Value Stocks Estimated To Be Up To 46.8% Below Intrinsic Value

Over the last 7 days, the United States market has remained flat, yet it has risen by 5.7% over the past year with earnings forecasted to grow by 13% annually. In this environment, identifying undervalued stocks that are trading below their intrinsic value can be a strategic approach for investors seeking opportunities in a stable yet growing market.

Read more